Alphamab Oncology Revenue and Competitors

苏州市,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Alphamab Oncology's estimated annual revenue is currently $6M per year.(i)
  • Alphamab Oncology's estimated revenue per employee is $201,000

Employee Data

  • Alphamab Oncology has 30 Employees.(i)
  • Alphamab Oncology grew their employee count by -3% last year.

Alphamab Oncology's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Alphamab Oncology?

Alphamab Oncology (Stock code: 9966.HK) is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment. With multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipeline in oncology/ immunology, and we are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally.

keywords:N/A

N/A

Total Funding

30

Number of Employees

$6M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Alphamab Oncology News

2022-04-19 - TRACON Pharmaceuticals receives amended ENVASARC protocol approval for its US and UK clinical sites

... in advanced biliary tract cancer patients in China sponsored by TRACON's corporate partners, Alphamab Oncology and 3D Medicines.

2022-04-19 - TRACON Pharmaceuticals Announces Amended ENVASARC ...

In December 2019, Alphamab Oncology, 3D Medicines and TRACON entered into a collaboration whereby TRACON has the right to develop and...

2022-03-30 - First Year of Commercialization, Alphamab Oncology Reports ...

Alphamab Oncology is committed to building a global leading, multi-dimensional drug development and commercialization platform, focusing on...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.7M32-22%N/A
#2
$2.7M33-38%N/A
#3
$6.2M35-3%N/A
#4
$13M592%N/A
#5
$67.8M22425%N/A